D-Dimer elevation and adverse outcomes.
Repository Usage Stats
D-Dimer is a biomarker of fibrin formation and degradation. While a D-dimer within normal limits is used to rule out the diagnosis of deep venous thrombosis and pulmonary embolism among patients with a low clinical probability of venous thromboembolism (VTE), the prognostic association of an elevated D-dimer with adverse outcomes has received far less emphasis. An elevated D-dimer is independently associated with an increased risk for incident VTE, recurrent VTE, and mortality. An elevated D-dimer is an independent correlate of increased mortality and subsequent VTE across a broad variety of disease states. Therefore, medically ill subjects in whom the D-dimer is elevated constitute a high risk subgroup in which the prospective evaluation of the efficacy and safety of antithrombotic therapy is warranted.
Fibrin Fibrinogen Degradation Products
Published Version (Please cite this version)10.1007/s11239-014-1101-6
Publication InfoChi, G; Cohen, A; Daaboul, Y; Gibson, Charles Michael; Goldhaber, SZ; Halaby, R; ... Zacarkim, MR (2015). D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis, 39(1). pp. 55-59. 10.1007/s11239-014-1101-6. Retrieved from http://hdl.handle.net/10161/13934.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Professor of Medicine
Associate Professor of Medicine
I am a cardiologist with a clinical and research interest in heart failure, including advanced therapies such as cardiac transplantation and mechanical assist devices or “heart pumps." I became a heart failure cardiologist in order to help patients manage their chronic disease over many months and years. I consider myself strongly committed to compassionate patient care with a focus on quality of life and patient preference.My research interests are focused on treating co-morbi
Alphabetical list of authors with Scholars@Duke profiles.